UPDATE : Friday, February 22, 2019
상단여백
SK Chemical to co-promote Janssen’s dementia treatment by Lee Han-soo 2019-02-12 15:55
US pharma group asks USTR to designate Korea as priority foreign country by Lee Han-soo 2019-02-11 17:49
IVI to cooperate with CEPI to develop vaccines by Lee Han-soo 2019-02-11 16:41
‘Lung function bigger factor than obesity in metabolic health’ by Lee Han-soo 2019-02-11 15:28
SMC introduces vNOTES surgery by Lee Han-soo 2019-02-11 13:20
라인
Samsung Bioepis, C-Bridge Capital to develop biosimilars in China by Lee Han-soo 2019-02-11 11:23
Novo Nordisk has high expectations for GLP-1 receptor agonists by Kim Yun-mi 2019-02-08 17:11
‘Total homocysteine increases risk of cerebral infarction’ by Lee Han-soo 2019-02-08 16:13
Pangen wins Malaysia’s nod for epoetin alfa biosimilar by Lee Han-soo 2019-02-08 16:13
Kainos Medicine starts developing treatment for multiple system atrophy by Lee Han-soo 2019-02-08 11:47
라인
‘Novartis’ Cosentyx, a cost-effective alternative to Humira’ by Lee Han-soo 2019-02-07 17:14
FDA starts inspecting SK Biopharm’s epilepsy treatment by Lee Han-soo 2019-02-07 16:01
LSK Global PS to conduct clinical trials of Mediforum’s dementia treatment by Lee Han-soo 2019-02-07 14:40
FDA OKs Daewoong’s BTX by Lee Han-soo 2019-02-07 11:09
Pfizer feeling bittersweet over Korea’s biosimilars by Lee Han-soo 2019-02-01 17:04
라인
Medytox, Daewoong continue to squabble over BTX by Lee Han-soo 2019-02-01 15:36
Samsung BioLogics posts ₩535.8 billion in 2018 sales by Lee Han-soo 2019-02-01 11:56
Santen Pharma to sell Huonland’s eye drop in China by Lee Han-soo 2019-02-01 11:56
Boryung Bio, CancerRop launch Wilson's disease screening test by Lee Han-soo 2019-02-01 10:59
AbClon transfers target antibody technology to GC Labcell by Lee Han-soo 2019-01-31 16:23
여백
여백
여백
Back to Top